Kyohei Fujita Selected Research

Anticoagulants

1/2023	A Case of Dural Arteriovenous Fistula Following Cerebral Venous Sinus Thrombosis Associated with the COVID-19 Vaccine.
1/2018	Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation　- SAMURAI-NVAF Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kyohei Fujita Research Topics

Disease

10	Stroke (Strokes) 12/2023 - 01/2018
9	Ischemic Stroke 01/2023 - 01/2018
3	Embolism (Embolus) 01/2024 - 01/2018
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 01/2018
3	Hemorrhage 12/2023 - 01/2022
3	COVID-19 01/2023 - 01/2021
2	Cerebral Small Vessel Diseases 12/2023 - 01/2022
2	Pathologic Constriction (Stenosis) 04/2022 - 01/2021
2	Infections 01/2021 - 01/2018
2	Venous Thromboembolism 01/2020 - 01/2019
2	Rupture 01/2020 - 10/2015
2	Transient Ischemic Attack 01/2019 - 01/2018
2	Hypertension (High Blood Pressure) 01/2019 - 01/2018
2	Atrial Fibrillation 01/2019 - 01/2018
1	Hydrocephalus (Hydrocephaly) 01/2024
1	Carotid Stenosis (Carotid Artery Stenosis) 01/2024
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2023
1	Intracranial Aneurysm (Cerebral Aneurysm) 11/2023
1	Infarction (Infarctions) 03/2023
1	Intracranial Sinus Thrombosis (Sinus Thrombosis) 01/2023
1	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 01/2023
1	Headache (Headaches) 01/2023
1	Heart Failure 01/2023
1	Vascular Diseases (Vascular Disease) 09/2022
1	Hypersensitivity (Allergy) 04/2022
1	Delayed Hypersensitivity (Hypersensitivity, Type IV) 04/2022
1	Paresis (Hemiparesis) 04/2022
1	Aneurysm (Aneurysms) 04/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Albuminuria 01/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Nausea 06/2020
1	Inflammation (Inflammations) 06/2020
1	Thrombosis (Thrombus) 06/2020
1	Cerebellar Ataxia (Dysmetria) 06/2020
1	Atopic Dermatitis (Atopic Eczema) 06/2020
1	Dizziness (Lightheadedness) 06/2020
1	Acute Coronary Syndrome 01/2020
1	Aortic Aneurysm (Aneurysm, Aortic) 01/2020
1	Peripheral Arterial Disease 01/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019
1	Leukemia 05/2017

Drug/Important Bio-Agent (IBA)

2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023 - 01/2022
2	AnticoagulantsIBA 01/2023 - 01/2018
2	VaccinesIBA 01/2023 - 01/2022
2	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2024
1	Dihydrotachysterol (AT 10)IBA 12/2023
1	A 7 (A-7)IBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	CalciumIBA 01/2023
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2022
1	Clopidogrel (Plavix)FDA Link 09/2022
1	MetalsIBA 04/2022
1	CobaltIBA 04/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Acetazolamide (Diamox)FDA LinkGeneric 01/2021
1	Interleukin-4 (Interleukin 4)IBA 06/2020
1	CytokinesIBA 06/2020
1	Interleukin-13IBA 06/2020
1	dupilumabIBA 06/2020
1	Protein SIBA 01/2019
1	Antihypertensive Agents (Antihypertensives)IBA 01/2019
1	Nicardipine (Dagan)FDA LinkGeneric 01/2018
1	Bone Morphogenetic Protein 2IBA 05/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 05/2017
1	ElementsIBA 10/2015

Therapy/Procedure

8	Therapeutics 12/2023 - 11/2019
4	Stents 01/2024 - 01/2021
3	Thrombectomy 01/2023 - 01/2021
1	Embolic Protection Devices 01/2024
1	Punctures 08/2022
1	Personal Protective Equipment 01/2021
1	Catheters 01/2021
1	N95 Respirators 01/2021
1	Carotid Endarterectomy 01/2020
1	Percutaneous Coronary Intervention 01/2020
1	Secondary Prevention 01/2018